India to United States: Ofloxacin Export Trade Route

The India to United States Ofloxacin corridor is one of India's established pharmaceutical export routes, with 992 shipments documented worth a combined $115.4M USD. The route is dominated by DR.REDDY'S LABORATORIES LTD, which alone accounts for roughly 26% of all export value, reflecting the consolidated nature of India's ofloxacin manufacturing sector.

Across 51 active suppliers, the average shipment value stands at $116.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with ofloxacin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 26.9%, placing it at rank #9 among India's top ofloxacin export destinations globally.

On the import side, key buyers of Indian ofloxacin in United States include DR REDDYS LABORATORIES INC, DR.REDDY'S LABORATORIES,INC, DR, REDDYS LABORATORIES, INC and 150 others. DR REDDYS LABORATORIES INC is the single largest importer with 26 shipments valued at $31.0M USD.

India's ofloxacin exports to United States are driven primarily by a handful of large-scale manufacturers. DR.REDDY'S LABORATORIES LTD with 62 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 51 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 63% of total trade value on this route. The average shipment value of $116.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension usp 7.5ml bottle and ciprofloxacin 0.3% and dexamethasone 0.1 , suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, DR REDDYS LABORATORIES INC is the largest importer with 26 shipments worth $31.0M USD — representing 27% of all ofloxacin imports from India on this route. A total of 153 buyers are active on this corridor.